Literature DB >> 10480260

Antiviral drug susceptibility assays: going with the flow.

J J McSharry1.   

Abstract

This review describes the procedures for the use of fluorochrome labeled monoclonal antibodies and flow cytometry for the detection and quantification of virus infected cells. The application of this technology for (1) identifying virus infected cells in clinical specimens obtained from human cytomegalovirus (HCMV) and human immunodeficiency virus (HIV) infected individuals; (2) screening antiviral compounds active against HCMV, HDSV and HIV; and (3) performing drug susceptibility testing for HCMV, HSV and HIV clinical isolates are reviewed. The flow cytometry drug susceptibility assay is rapid, quantitative, and easily performed. It should be considered by anyone interested in performing drug susceptibility testing for any virus for which there are reliable monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480260     DOI: 10.1016/s0166-3542(99)00039-x

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir.

Authors:  Christine Chutkowski; Betty Olson; Ann McDonough; James Mahoney; James J McSharry
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.

Authors:  J J McSharry; A McDonough; B Olson; C Talarico; M Davis; K K Biron
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir.

Authors:  J J McSharry; A McDonough; B Olson; S Hallenberger; J Reefschlaeger; W Bender; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 4.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

5.  Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.

Authors:  James J McSharry; Ann C McDonough; Betty A Olson; George L Drusano
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.